Mind Body Program for Fear of Recurrence
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 23
- 试验地点
- 1
- 主要终点
- Acceptability
研究概览
简要总结
This is a pilot feasibility study of a group-based, mind body intervention for managing stress and fear of recurrence and promoting resiliency among adult cancer survivors.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must have a history of breast, lung, colorectal, hematologic, prostate, melanoma, or gynecological cancer (by medical record and/or self-report)
- •Completion of primary cancer treatment (radiation, surgery, and/or chemotherapy) between 3 to 30 months ago
- •Ages 18 and older (by medical record and/or self-report)
排除标准
- •Self-reported inability to speak and write in English
- •Concurrent participation in weekly, group-based psychosocial or mind-body programs
- •Serious mental illness (by medical record and/or self-report) as defined by history of suicidality, psychosis, and/or psychiatric hospitalization in the past year.
- •Inability to travel to necessary study visits
- •No e-mail address to access online assessments
研究组 & 干预措施
Mind-Body Group Intervention
干预措施: Mind-Body Program for Fear of Recurrence (Behavioral)
结局指标
主要结局
Acceptability
时间窗: During intervention group sessions (approximately 2 months)
The primary metric for assessing Acceptability will be a five-item, investigator developed self-report questionnaire. Following each study session, participants will be asked to rate (1=not at all to 5=very much) the enjoyableness, convenience, helpfulness, relevancy, odds of future use, and overall satisfaction of the session.
Feasibility (i.e., retention at initial follow-up assessment)
时间窗: Through study completion (approximately 5 months)
The primary metric for assessing Feasibility will be retention at the initial follow-up assessment. Reasons for ineligibility, refusal, or dropping out will be measured.
次要结局
- Fear of Cancer Recurrence(Baseline, 8 weeks (Post-intervention), 1 month follow-up, 3 months follow-up)
研究者
Gloria Y. Yeh
Associate Professor of Medicine
Beth Israel Deaconess Medical Center